Find Federal Grants
Department of Homeland Security - FEMA · DHS-24-GPD-008-00-98
Bureau of International Narcotics-Law Enforcement · OFOP0001654
Early Head Start Expansion and Early Head Start-Child Care Partnership Grants - Multiple Communities in GA, LA, MD, MI, NJ, NY, OH, VA, WI
Administration for Children and Families - OHS · HHS-2025-ACF-OHS-HP-0125
Head Start/Early Head Start Recipient - Multiple Communities in AZ, AR, CA, CO, CT, FL, GA, IL, IN, KS, LA, MD, MA, MI, MN, MS, MT, NJ, NM, NY, NC, OH, OR, PA, PR, SC, SD, TN, TX, VT, VA, WA, WI
Administration for Children and Families - OHS · HHS-2025-ACF-OHS-CH-0124
Health Resources and Services Administration · HRSA-25-027
Bureau of International Security-Nonproliferation · DFOP0016994
Build Partner Capabilities to Counter the Russian Federation’s Chemical and Biological Threats
Bureau of International Security-Nonproliferation · DFOP0016992
Bureau of International Security-Nonproliferation · DFOP0016995
Advancing Nuclear Safety, Security, and Nonproliferation through the FIRST Program
Bureau of International Security-Nonproliferation · DFOP0016986
Bureau of International Security-Nonproliferation · DFOP0016993
Bureau of International Security-Nonproliferation · DFOP0016991
Bureau of International Security-Nonproliferation · DFOP0016990
Bureau of International Security-Nonproliferation · DFOP0016985
Bureau of International Security-Nonproliferation · DFOP0016989
Bureau of International Security-Nonproliferation · DFOP0016988
Build Partner Resilience to Counter Proliferator State Hybrid Threats in the Nonproliferation Arena
Bureau of International Security-Nonproliferation · DFOP0016984
Bureau of International Security-Nonproliferation · DFOP0016987
Bureau of Population Refugees and Migration · DFOP0016956
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-213
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required)
National Institutes of Health · PAR-25-223